CHRISTINE ALEXOPOULOS: Open Payments
NPI 1235862210 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 55 payments from 12 companies in 2025. Trend: 2023 $474 · 2024 $1,497 · 2025 $2,738
Food & beverage: $2,639Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $754 |
| ABBVIE INC. | 18 | $620 |
| Janssen Biotech, Inc. | 10 | $553 |
| GENZYME CORPORATION | 3 | $401 |
| GlaxoSmithKline, LLC. | 4 | $120 |
| Exact Sciences Corporation | 1 | $99 |
| Mallinckrodt Hospital Products Inc. | 3 | $68 |
| Genentech USA, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
Products named: TREMFYA, RINVOQ, KEVZARA, TAVNEOS, SKYRIZI, KRYSTEXXA, EVENITY, UPLIZNA.
Industry payments across CA — which companies pay providers there.
